Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Ile-Pro-Pro and Val-Pro-Pro tripeptide-containing milk product has acute blood pressure lowering effects in mildly hypertensive subjects.

Turpeinen AM, Ehlers PI, Kivimäki AS, Järvenpää S, Filler I, Wiegert E, Jähnchen E, Vapaatalo H, Korpela R, Wagner F.

Clin Exp Hypertens. 2011;33(6):388-96. doi: 10.3109/10641963.2010.549267. Epub 2011 Jun 7.

PMID:
21649532
2.

Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.

Hajda JP, Jähnchen E, Oie S, Trenk D.

J Clin Pharmacol. 2002 Nov;42(11):1257-61.

PMID:
12412825
3.

Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon.

Russmann S, Dilger K, Trenk D, Nagyivanyi P, Jähnchen E.

Arzneimittelforschung. 2001 Nov;51(11):891-5.

PMID:
11765590
4.

Pharmacokinetics of tilidine in terminal renal failure.

Seiler KU, Jähnchen E, Trenk D, Brennscheidt U, Heintz B.

J Clin Pharmacol. 2001 Jan;41(1):79-84.

PMID:
11144998
5.
6.

Age-dependent differences in the anticoagulant effect of phenprocoumon in patients after heart valve surgery.

Russmann S, Gohlke-Bärwolf C, Jähnchen E, Trenk D, Roskamm H.

Eur J Clin Pharmacol. 1997;52(1):31-5.

PMID:
9143864
7.

A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.

Breslin E, Posvar E, Neub M, Trenk D, Jahnchen E.

J Clin Pharmacol. 1996 May;36(5):414-21.

PMID:
8739020
8.

Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimine.

Stengele E, Ruf G, Jähnchen E, Trenk D, Löffler K, Schulz W, Roskamm H.

Am J Cardiol. 1996 May 1;77(11):937-41.

PMID:
8644642
9.

Digital pulse plethysmography as a non-invasive method for predicting drug-induced changes in left ventricular preload.

Stengele E, Winkler F, Trenk D, Jähnchen E, Petersen J, Roskamm H.

Eur J Clin Pharmacol. 1996;50(4):279-82.

PMID:
8803519
10.

Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazem.

Della Paschoa OE, Luckow V, Trenk D, Jähnchen E, Santos SR.

Eur J Clin Pharmacol. 1995;48(1):45-9.

PMID:
7621847
11.

Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.

Ruf G, Trenk D, Jähnchen E, Roskamm H.

Int J Cardiol. 1994 Mar 1;43(3):279-85.

PMID:
7910155
12.

[Clinico-pharmacologic aspects of therapy with enoximone].

Trenk D, Jähnchen E.

Z Kardiol. 1994;83 Suppl 2:7-14. Review. German.

PMID:
8091828
13.

Pharmacokinetics and pharmacodynamics of ramipril and piretanide administered alone and in combination.

Ruf G, Gera S, Luus HG, Trenk D, de la Rey N, Löffler K, Schulz W, Jähnchen E.

Eur J Clin Pharmacol. 1994;46(6):545-50.

PMID:
7995323
14.

Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration.

Vogt D, Trenk D, Bonn R, Jähnchen E.

Eur J Clin Pharmacol. 1994;46(4):319-24.

PMID:
7957516
15.

Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.

Trenk D, Möhrke W, Warth L, Jähnchen E.

Arzneimittelforschung. 1993 Aug;43(8):836-41.

PMID:
8216438
16.

Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration.

Kovarik JM, Mueller EA, Gaber M, Johnston A, Jähnchen E.

J Clin Pharmacol. 1993 Jun;33(6):513-21.

PMID:
8366176
17.

Effect of concomitantly administered cimetidine or ranitidine on the pharmacokinetics of the 5-HT2-receptor antagonist ritanserin.

Trenk D, Seiler KU, Buschmann M, Szathmary S, Benn HP, Jähnchen E.

J Clin Pharmacol. 1993 Apr;33(4):330-4.

PMID:
8473547
18.

Comparison of the effects of two different galenical preparations of glyceryl trinitrate on pulmonary artery pressure and on the finger pulse curve.

Buschmann M, Wiegand A, Schnellbacher K, Bonn R, Rehe A, Trenk D, Jähnchen E, Roskamm H.

Eur J Clin Pharmacol. 1993;44(5):451-6.

PMID:
8359182
19.

Pharmacodynamic and pharmacokinetic evaluation of a new transdermal delivery system with a time-dependent release of glyceryl trinitrate.

Wiegand A, Bauer KH, Bonn R, Trenk D, Jähnchen E.

J Clin Pharmacol. 1992 Jan;32(1):77-84.

PMID:
1740541
20.
21.
22.

[Interactions between digitoxin, flecainide and prajmalium bitartrate?].

Jähnchen E.

Dtsch Med Wochenschr. 1991 Jun 28;116(26):1035-6. German. No abstract available.

PMID:
1905622
23.

Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.

Hohnloser SH, Meinertz T, Dammbacher T, Steiert K, Jähnchen E, Zehender M, Fraedrich G, Just H.

Am Heart J. 1991 Jan;121(1 Pt 1):89-95.

PMID:
1985383
24.

[Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].

Birnbaum DE, Preuner JG, Gieseke R, Kasper-König W, Trenk D, Jähnchen E, Dieterich HA.

Z Kardiol. 1991;80 Suppl 4:47-52. German.

PMID:
1833897
25.

[Pharmacology and pharmacokinetics of enoximone].

Jähnchen E, Trenk D.

Z Kardiol. 1991;80 Suppl 4:21-6. Review. German.

PMID:
1833893
26.

[Drug interactions with oral anticoagulants].

Jähnchen E.

Vasa Suppl. 1991;33:77-8. German. No abstract available.

PMID:
1788771
27.

Haemodynamic effects of glyceryl trinitrate following repeated application of a transdermal delivery system with a phasic release profile.

Wiegand A, Bonn R, Wagner F, Trenk D, Jähnchen E.

Eur J Clin Pharmacol. 1991;41(2):115-8.

PMID:
1743242
28.

Lack of effect of cefixime on the metabolism of vitamin K1.

Trenk D, Wagner F, Bechtold H, Nies B, Jähnchen E.

J Clin Pharmacol. 1990 Aug;30(8):737-42.

PMID:
2401753
29.

Lack of effect of enoximone on the pharmacokinetics of digoxin in patients with congestive heart failure.

Trenk D, Hertrich F, Winkelmann B, Glauner T, Dieterich HA, Jähnchen E.

J Clin Pharmacol. 1990 Mar;30(3):235-40.

PMID:
2138170
30.

Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate.

Wagner F, Siefert F, Trenk D, Jähnchen E.

Eur J Clin Pharmacol. 1990;38 Suppl 1:S53-9.

PMID:
2354713
31.

Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.

Trenk D, Wagner F, Sachs W, Jähnchen E.

Eur J Clin Pharmacol. 1989;37(3):313-6.

PMID:
2612546
32.

Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.

Wagner F, Jähnchen E, Trenk D.

Eur J Clin Pharmacol. 1989;36(6):579-82.

PMID:
2570700
33.

Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.

Hauf GF, Grom E, Jähnchen E, Roskamm H.

J Cardiovasc Pharmacol. 1989;14 Suppl 2:S49-56.

PMID:
2478793
34.

Sex-related differences in disposition and response to phenprocoumon in rats.

Trenk D, Jähnchen E, Oie S.

J Pharm Pharmacol. 1988 Jun;40(6):403-7.

PMID:
2901471
35.

Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.

Trenk D, Winkelmann B, Jähnchen E, Oie S.

J Pharmacokinet Biopharm. 1988 Feb;16(1):1-12.

PMID:
3373415
36.

Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.

Shearer MJ, Bechtold H, Andrassy K, Koderisch J, McCarthy PT, Trenk D, Jähnchen E, Ritz E.

J Clin Pharmacol. 1988 Jan;28(1):88-95.

PMID:
3350995
37.

[Therapeutic systems--possibilities and limits].

Meinertz T, Jähnchen E, Just H.

Verh Dtsch Ges Inn Med. 1988;94:436-41. Review. German. No abstract available.

PMID:
3144813
38.

Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.

Wagner F, Jähnchen E, Trenk D, Eichelbaum M, Harnasch P, Hauf G, Roskamm H.

Klin Wochenschr. 1987 Dec 15;65(24):1164-8.

PMID:
3437726
39.

Time course of cyclosporin/itraconazole interaction.

Trenk D, Brett W, Jähnchen E, Birnbaum D.

Lancet. 1987 Dec 5;2(8571):1335-6. No abstract available.

PMID:
2890938
40.

Pharmacokinetics and bioavailability of piretanide in healthy volunteers following intramuscular administration.

Trenk D, Wagner F, Jähnchen E, Spahn H, Mutschler E.

Arzneimittelforschung. 1987 Dec;37(12):1382-5.

PMID:
3449067
41.

Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers.

Trenk D, Wagner F, Jähnchen E, Plänitz V.

J Clin Pharmacol. 1987 Dec;27(12):988-93.

PMID:
3437071
42.

Alinidine in heart patients: electrophysiologic and antianginal actions.

Meinertz T, Kasper W, Jähnchen E.

Eur Heart J. 1987 Dec;8 Suppl L:109-14.

PMID:
3330524
43.

Drug interaction between propafenone and metoprolol.

Wagner F, Kalusche D, Trenk D, Jähnchen E, Roskamm H.

Br J Clin Pharmacol. 1987 Aug;24(2):213-20.

44.

Hemostasis in patients with normal and impaired renal function under treatment with cefodizime.

Andrassy K, Koderisch J, Trenk D, Jähnchen E, Iwand A.

Infection. 1987;15(5):348-50.

PMID:
3692605
45.

Factors responsible for interindividual differences in the dose requirement of phenprocoumon.

Trenk D, Althen H, Jähnchen E, Meinertz T, Oie S.

Eur J Clin Pharmacol. 1987;33(1):49-54.

PMID:
3691595
46.

Relationship between pharmacokinetics and pharmacodynamics of organic nitrates.

Jähnchen E.

Z Kardiol. 1986;75 Suppl 3:12-5. Review.

PMID:
3099483
47.

Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans.

Meinertz T, Brandstätter A, Trenk D, Jähnchen E, Ostrowski J, Gärtner W.

Am Heart J. 1985 Mar;109(3 Pt 2):644-8.

PMID:
3838400
48.

Prehepatic and hepatic first-pass metabolism of lorcainide in rats.

Plänitz V, Grönniger J, Jähnchen E.

Arzneimittelforschung. 1985;35(6):923-6.

PMID:
4026917
49.

Lack of effect of propranolol on the steady-state plasma levels of ketanserin.

Trenk D, Lühr A, Radkow N, Jähnchen E.

Arzneimittelforschung. 1985;35(8):1286-8.

PMID:
2934070
50.

Determination of bupivacaine in human plasma by high-performance liquid chromatography.

Wiegand UW, Chou RC, Lanz E, Jähnchen E.

J Chromatogr. 1984 Nov 9;311(1):218-22. No abstract available.

PMID:
6520167

Supplemental Content

Loading ...
Support Center